Health Care Fraud Tipsters May Get Bigger Reward; Novartis Kickback Complaint Prompts CIA Review
This article was originally published in The Pink Sheet Daily
Executive Summary
HHS proposes to increase the potential reward for information leading to recovery of Medicare funds from $1,000 to $9.9 million; OIG is reviewing Novartis corporate integrity agreement compliance after government alleges company paid Myfortic kickbacks to pharmacies.
You may also be interested in...
Novartis To Make Its Medical Education Programs Virtual Under DOJ Settlement
Two settlements totaling $729m resolve kickback claims related to speaker programs and copay charities; Novartis will limit payments to healthcare professionals for providing medical education under a new corporate integrity agreement.
Kickback Suit Against Novartis Can Proceed, Judge Says
Federal judge rules against Novartis’ motion to dismiss a whistleblower suit alleging violations of the anti-kickback statute and the False Claims Act, saying the government’s evidence is specific enough to proceed.
Third Strike For Novartis: DOJ Alleges Firm Paid Kickbacks To Specialty Pharmacies
Government has intervened in a whistleblower suit alleging Novartis provided financial incentives to CVS Caremark and other specialty pharmacies to get them to recommend Exjade, Gleevec, and other Novartis drugs.